Search results
Results from the WOW.Com Content Network
Irish Medicines Formulary (IMF) [1] [2] is a medicines reference for doctors, nurses, pharmacists and dentists, [3] providing medicines information which is medico-legally relevant in Ireland. As of March 2025, the publication will only be published in digital format (IMF Edition 36 due for publication during March 2025).
[2] [6] A study in Northern Ireland, looking at prescribing in 1965, reported that the BNF was likely able to serve the requirements of prescribers in general practice, while also achieving a cost saving. [7] By 2003, issue 46 of the BNF contained 3000 interactions or groups of interactions, with about 900 of these marked by a bullet. [8] [9 ...
This is a list of abbreviations used in medical prescriptions, including hospital orders (the patient-directed part of which is referred to as sig codes).This list does not include abbreviations for pharmaceuticals or drug name suffixes such as CD, CR, ER, XT (See Time release technology § List of abbreviations for those).
Norbrook is a United Kingdom-based pharmaceutical company. It was founded in 1969 by Lord Ballyedmond as Norbrook Laboratories Ltd in Northern Ireland.In 1970, Norbrook began manufacturing of veterinary pharmaceuticals.
A formulary is a list of pharmaceutical drugs, often decided upon by a group of people, for various reasons such as insurance coverage or use at a medical facility. [1] Traditionally, a formulary contained a collection of formulas for the compounding and testing of medication (a resource closer to what would be referred to as a pharmacopoeia ...
In 2017 the NHS spent £475.3 million on over-the-counter drugs, and, despite the promises of up to £100 million in savings, £449.4 million in 2018, a reduction of only £25.9 million. [ 18 ] In April 2019 the All Wales Prescribing Advisory Group rejected the proposals for limiting the prescription of over-the-counter drugs.
The MHRA and the US Food and Drug Administration were criticised in the 2012 book Bad Pharma, [43] and in 2004 by David Healy in evidence to the House of Commons Health Committee, [44] for having undergone regulatory capture, i.e. advancing the interests of the drug companies rather than the interests of the public.
In 1963 Edward G Feldmann, director of revision for the US National Formulary, described it as "a compilation of highly authoritative and useful therapeutic (actions and doses) information as well as a valuable compendium of recognised standards and specifications". [2] In 1979 a new edition was published with a new title, The Pharmaceutical Codex.